[1]
“Surgical approach with vascular reconstruction after an objective response to neoadjuvant therapy with an EGFR tyrosine kinase inhibitor: clinical case”., Вопр. онкол., vol. 67, no. 2, pp. 278–281, May 2022, doi: 10.37469/0507-3758-2021-67-2-278-281.